Recent

% | $
Quotes you view appear here for quick access.

Synergy Pharmaceuticals, Inc. Message Board

  • ding_king2000 ding_king2000 Jan 3, 2013 6:25 AM Flag

    "SP-333, to our knowledge, represents the most proteolytically stable analog of uroguanylin - the physiological agonist of GC-C - ever developed, and is designed to remain biologically active in the gut, a factor we consider ideal for its potential use in treating UC."

    "SP-333, to our knowledge, represents the most proteolytically stable analog of
    uroguanylin - the physiological agonist of GC-C - ever developed, and is
    designed to remain biologically active in the gut, a factor we consider ideal
    for its potential use in treating UC."

 
SGYP
9.12+0.53(+6.17%)Jul 31 4:00 PMEDT